Treating Sleep Wake Cycle Disturbances in Basal Ganglia Neurodegenerative Disorder Subjects With Ramelteon- A Double Blind, Placebo Controlled Trial.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2012
At a glance
- Drugs Ramelteon (Primary)
- Indications Dyssomnias
- Focus Therapeutic Use
- 07 Jul 2010 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 05 May 2010 Official Title amended as reported by ClinicalTrials.gov.
- 27 May 2009 New trial record